摘要
目的评价卡介苗与羟基喜树碱在TURBT术后灌注治疗的对比疗效。方法回顾性分析2009年2月~2013年7月卡介苗与羟基喜树碱在TURBT术后灌注治疗的疗效对比观察的临床资料,其中卡介苗组57例,羟基喜树碱组48例,术后病理分型均为尿路上皮癌,比较2组的肿瘤病理分级、术后复发时间、术后复发率及并发症率。术后随访时间6月~48月,平均30月。结果两组肿瘤分期分级、术后复发时间、术后复发率及并发症率无明显差异。结论卡介苗与羟基喜树碱在TURBT术后灌注治疗中疗效无明显差异。
Objective To assess Comparative efficacy of BCG and HCPT instillation after TURBT treatment.Methods Retrospective analysis of the clinical data of observation from February to 2013in 2009 July with HCPT and BCG perfusion after TURBT treatment,the BCG group 57 cases,HCPT group 48 cases,postoperative pathological types wereurothelial carcinoma,tumor pathological grades,2 groups of postoperative recurrence time,postoperative recurrence rate and complication rate.Postoperative fol ow-up time in 6~48 months,average 30 months.Results Two groups of tumor stage and grade,recurrence time,postoperative recurrence rate and complication rate has no obvious dif erence.Conclusion No significant difference of BCG and the ef ect of HCPT in infusion therapy after TURBT'operation.
作者
何贫
冯征云
佘先
HE Pin;FENG Zheng-yun;Shexian(Department of Surgery,Pixian Chinese Medical Hospital,Chengdu 611730,Sichuan,China;Department of Urology,Qianjiang Central Hospital of Chongqing,Chongqing 409000,China)
